C-Mer Eye Care Holdings (HKSE:03309) Additional Paid-In Capital : HK$1,693 Mil(As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings Additional Paid-In Capital?

C-Mer Eye Care Holdings's quarterly additional paid-in capital stayed the same from Dec. 2022 (HK$1,733 Mil) to Jun. 2023 (HK$1,733 Mil) and stayed the same from Jun. 2023 (HK$1,733 Mil) to Dec. 2023 (HK$1,693 Mil).

C-Mer Eye Care Holdings's annual additional paid-in capital increased from Dec. 2021 (HK$1,087 Mil) to Dec. 2022 (HK$1,733 Mil) but then declined from Dec. 2022 (HK$1,733 Mil) to Dec. 2023 (HK$1,693 Mil).

C-Mer Eye Care Holdings Additional Paid-In Capital Historical Data

The historical data trend for C-Mer Eye Care Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings Additional Paid-In Capital Chart

C-Mer Eye Care Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

653.42

1,071.70

1,086.72

1,733.13

1,692.60

C-Mer Eye Care Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial													1,086.72	-	1,733.13	1,733.13	1,692.60

C-Mer Eye Care Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

C-Mer Eye Care Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Mer Eye Care Holdings (HKSE:03309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG

Website

https://www.cmereye.com

C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.

Executives

C-mer Group Limited	2101 Beneficial owner
Lam Shun Chiu Dennis	2201 Interest of corporation controlled by you
Li Xiaoting	2201 Interest of corporation controlled by you

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines